2021
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
Lusczek ER, Ingraham NE, Karam BS, Proper J, Siegel L, Helgeson ES, Lotfi-Emran S, Zolfaghari EJ, Jones E, Usher MG, Chipman JG, Dudley RA, Benson B, Melton GB, Charles A, Lupei MI, Tignanelli CJ. Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles. PLOS ONE 2021, 16: e0248956. PMID: 33788884, PMCID: PMC8011766, DOI: 10.1371/journal.pone.0248956.Peer-Reviewed Original ResearchConceptsCOVID-19 patientsClinical phenotypePhenotype IIIClinical outcomesCOVID-19 clinical phenotypesHours of admissionPhenotype IHazard of deathCoronavirus disease 2019Specific clinical phenotypesCOVID-19 phenotypesHospital complicationsRespiratory comorbiditiesPatient comorbiditiesDifferent comorbiditiesComplication profilePatient populationAdmission characteristicsMultivariable modelRetrospective analysisDisease 2019ComorbiditiesTrial designPatientsClinical practice
2017
Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion
Berry JL, Zolfaghari E, Chen A, Murphree AL, Jubran R, Kim JW. Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion. Ocular Oncology And Pathology 2017, 3: 283-291. PMID: 29344482, PMCID: PMC5757559, DOI: 10.1159/000464468.Peer-Reviewed Original ResearchOptic nerve invasionNerve invasionAdvanced retinoblastomaOptic nervePostlaminar optic nerve invasionPoor prognostic signPostlaminar invasionSalvage therapySalvage groupPrimary enucleationGlobe salvageRetrospective reviewPrognostic signRisk factorsIntraocular tumorsHistopathologic analysisSmall cohortNervePatientsDiagnosisRetinoblastomaEyesSecond groupInvasionTreatment